From the Medical Board of the National Psoriasis Foundation: Recommendations for screening for hepatitis B infection prior to initiating anti–tumor necrosis factor-alfa inhibitors or other immunosuppressive agents in patients with psoriasis

This publication has 38 references indexed in Scilit:

• Consensus Guidelines for the Management of Plaque Psoriasis
  Archives of Dermatology, 2012
• Hepatitis B Virus Reactivation by Immunosuppressive Therapy in Patients with Autoimmune Diseases: Risk Analysis in Hepatitis B Surface Antigen-negative Cases
  The Journal of Rheumatology, 2011
• Current trends in management of hepatitis B virus reactivation in the biologic therapy era
  World Journal of Gastroenterology, 2011
• Possible Reactivation of Potential Hepatitis B Virus Occult Infection by Tumor Necrosis Factor-α Blocker in the Treatment of Rheumatic Diseases
  The Journal of Rheumatology, 2009
• Chronic hepatitis B: Update 2009 #
  Hepatology, 2009
• Reactivation of hepatitis B # †
  Hepatology, 2009
• Reactivation of hepatitis B: Pathogenesis and clinical implications
  Current Infectious Disease Reports, 2009
• Chronic hepatitis B
  Hepatology, 2007
• Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies
  Annals of the Rheumatic Diseases, 2006
• Tumor Necrosis Factor (TNF)-alpha and TNF Receptors in Viral Pathogenesis
  Proceedings of the Society for Experimental Biology and Medicine, 2000